Stay ahead in the booming mRNA market, projected to reach $63.28 billion by 2025, with the 3rd mRNA Process Development & Manufacturing Summit 2025—Europe’s premier industry-focused forum dedicated to optimizing mRNA therapeutics and vaccine development.
Download the eBook
The official event guide is your go-to resource for navigating the latest advancements in continuous processing, advanced analytics, scalable manufacturing, and regulatory compliance to accelerate approvals and ensure patients receive life-saving treatments faster.
With insights from industry leaders like CEPI, Merck, CureVac, BioNTech, and more, this guide is essential for staying competitive in mRNA process development and manufacturing.
Download your copy now and optimize your path to scalable, cost-efficient mRNA production.
Download the eBook
About Hanson Wade Group - 3rd mRNA Process Development & Manufacturing Europe
With the mRNA market projected to reach $63.28 billion by 2025, the global demand for mRNA vaccines and therapeutics is at an all-time high.
Now more than ever, robust process development and manufacturing are essential to ensure patients have access to life-saving treatments. While the industry is making strides in continuous processing, advanced analytics, improved scalability, and innovative formulations, significant challenges remain, including controlling impurities, long manufacturing timelines, and navigating complex regulatory pathways for timely approvals.
The 3rd mRNA Process Development & Manufacturing Summit 2025 returns as Europe’s premier industry-focused forum, dedicated to optimizing process development for mRNA therapeutics and vaccines. This event will address end-to-end process optimisation, regulatory compliance to streamline approvals, while also advancing scalable and cost-efficient manufacturing solutions, to support drug developers in delivering safer and more effective mRNA drugs to patients faster.
Bringing together leading experts from CEPI, Merck, CureVac, BioNTech, Altamira, Genevation, and more, this summit will showcase cutting-edge advancements in end-to-end process development and manufacturing to support the production of high-quality, cost-effective mRNA therapeutics at scale.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.